Vitamin D: From Photosynthesis, Metabolism, and Action to Clinical Applications

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 1, Issue , 2010, Pages 1089-1110

  Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944536418     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00058-7     Document Type: Chapter

References (272)

1. D Whistler (1645) Morbo puerili Anglorum, quem patrio idiomate indigenae vocant. The Rickets. Lugduni Batavorum pp 1–13
2. F Glisson (1650) De Rachitide sive morbo puerili, qui vulgo. London: The Rickets diciteur pp 1–416
3. W Mozolowski (1939) Jedrzej Sniadecki (1768–1883) on the cure of rickets. Nature 143 121.
4. TA Palm (1890) The geographic distribution and etiology of rickets. Practitioner 45 321-342.
5. K Huldshinsky (1919) Heilung von Rachitis durch künstliche Höhensonne. Dtsch Med Wochenschr 45 712-713.
6. HP Chick, EJ Dalyell, EM Hume, et al. (1923) Studies of rickets in Vienna 1919–1922. Medical Research Council Special Report Series, No. 77. London: Medical Research Council
7. AF Hess and M Weinstock (1924) Antirachitic properties imparted to lettuce and to growing wheat by ultraviolet irradiation. Proc Soc Exp Biol Med 22 5-6.
8. E Mellanby and MD Cantag (1919) Experimental investigation on rickets. Lancet 196 407-412.
9. EV McCollum, N Simmonds and W Pitz (1916) The relation of unidentified dietary factors, the fat-soluble A and water-soluble B of the diet to the growth promoting properties of milk. J Biol Chem 27 33-38.
10. EV McCollum, N Simmonds, JE Becker, et al. (1922) Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 53 293-312.
11. H Goldblatt and KN Soames (1923) A study of rats on a normal diet irradiated daily by the mercury vapor quartz lamp or kept in darkness. Biochem J 17 294-297.
12. A Windaus and O Linsert (1928) Vitamin D1. Ann Chem 465 148.
13. BL Specker, RC Tsang and BW Hollis (1985) Effect of race and diet on human-milk vitamin-D and 25-hydroxyvitamin D. Am J Dis Child 139 1134-1137.
14. BW Hollis (2007) Vitamin D requirement during pregnancy and lactation. J Bone Miner Res 22 V39-V44.
15. MF Holick (1987) Vitamin D and the kidney. Kidney Intl 32 912-929.
16. MF Holick (2007) Vitamin D deficiency. N Engl J Med 357 266-281.
17. TC Chen, Q Shao, H Heath, et al. (1993) An update on the vitamin-D content of fortified milk from the United States and Canada. N Engl J Med 329 1507.
18. MF Holick, Q Shao, WW Liu, et al. (1992) The vitamin D content of fortified milk and infant formula. N Engl J Med 326 1178-1181.
19. SP Murphy and DH Calloway (1986) Nutrient intakes of women in NHANES II, emphasizing trace minerals, fiber, and phytate. J Am Diet Assoc 86 1366-1372.
20. EA Krall, N Sahyoun, S Tannenbaum, et al. (1989) Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women. N Engl J Med 321 1777-1783.
21. C Lamberg-Allardt, M Karkkainen, R Seppanen, et al. (1993) Low serum 25-hydroxyvitamin D concentrations and secondary hyperparathyroidism in middle-aged white strict vegetarians. Am J Clin Nutr 58 684-689.
22. AW Norman, R Bouillon, SJ Whiting, et al. (2007) 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103 204-205.
23. European Food Safety Authority Scientific Committee on Food Scientific Panel on Dietetic Products, Nutrition and Allergies (2006) Tolerable upper intake levels for vitamin D and minerals. http://www.efsa.europa.eu/
24. R Bouillon, G Carmeliet, L Verlinden, et al. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29 726-776.
25. RI Kelley (1998) RXH/Smith-Lemli-Opitz syndrome: mutations and metabolic morphogenesis. Am J Hum Genet 63 322-326.
26. C Cunniff, LE Kratz, A Moser, et al. (1997) Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet 68 263-269.
27. M Rossi, G Federico, G Corso, et al. (2005) Vitamin D status in patients affected by Smith-Lemli-Opitz syndrome. J Inherit Metab Dis 28 69-80.
28. JP Bonjour, U Trechsel, E Granzer, et al. (1987) The increase in skin 7-dehydrocholesterol induced by an hypocholesterolemic agent is associated with elevated 25-hydroxyvitamin D3 plasma level. Pflügers Arch 410 165-168.
29. JG Morris (1997) Ineffective synthesis of vitamin D in kittens exposed to sun or UV light is reversed by an inhibitor of 7-dehydrocholesterol-delta7-reductase. AW Norman, R Bouillon, M Thomasset,(Eds) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone Riverside, CA: University of California 721-722.
30. B Oliveri, S Zeni, MP Lorenzetti, et al. (1999) Effect of one year residence in Antarctica on bone mineral metabolism and body composition. Eur J Clin Nutr 53 88-91.
31. X Du, H Greenfield, DR Fraser, et al. (2001) Vitamin D deficiency and associated factors in adolescent girls in Beijing. Am J Clin Nutr 74 494-500.
32. P Lips (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22 477-501.
33. P Lips (2004) Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89–90 611-614.
34. P Lips (2007) Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 103 620-625.
35. C Munns, MR Zacharin, CP Rodda, et al. (2006) Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Med J Aust 185 268-272.
36. Working Group of the Australian and New Zealand Bone and Mineral Society ESoAaOA (2005) Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 182 281-285.
37. M Gascon-Barré (2005) The vitamin D 25-hydroxylase. D Feldman, JW Pike, FH Glorieux,(Eds) Vitamin D San Diego: Academic Press 47-67.
38. HL Henry (2005) The 25-hydroxyvitamin D 1α-hydroxylase. D Feldman, JW Pike, FH Glorieux,(Eds) Vitamin D San Diego: Academic Press 69-83.
39. JW Blunt, HF DeLuca and HK Schnoes (1968) 25-Hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry 7 3317-3322.
40. G Ponchon, AL Kennan and HF DeLuca (1969) “Activation” of vitamin D by the liver. J Clin Invest 48 2032-2037.
41. H Postlind, E Axen, T Bergman, et al. (1997) Cloning, structure, and expression of a cDNA encoding vitamin D3 25-hydroxylase. Biochem Biophys Res Commun 241 491-497.
42. JB Cheng, MA Levine, NH Bell, et al. (2004) Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 101 7711-7715.
43. N Maeda, A Reshef, A Lippoldt, et al. (1998) Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem 273 14805-14812.
44. MH Bhattacharyya and HF DeLuca (1974) The regulation of calciferol-25-hydroxylase in the chick. Biochem Biophys Res Commun 59 734-741.
45. DR Fraser and E Kodicek (1970) Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature 228 764-766.
46. R Nicolaysen, N Eeglarsen and J Malm (1953) Physiology of calcium metabolism. Physiol Rev 33 424-444.
47. T Monkawa, T Yoshida, S Wakino, et al. (1997) Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1α-hydroxylase. Biochem Biophys Res Commun 239 527-533.
48. GK Fu, D Lin, MYH Zhang, et al. (1997) Cloning of human 25-hydroxyvitamin D-1α-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 11 1961-1970.
49. R St-Arnaud, S Messerlian, JM Moir, et al. (1997) The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 12 1552-1559.
50. K Takeyama, S Kitanaka, T Sato, et al. (1997) 25-Hydroxyvitamin D3 1α-hydroxylase and vitamin D synthesis. Science 277 1827-1830.
51. T Shinki, H Shimada, S Wakino, et al. (1997) Cloning and expression of rat 25-hydroxyvitamin D3–1α-hydroxylase cDNA. Proc Natl Acad Sci U S A 94 12920-12925.
52. L Overbergh, B Decallonne, D Valckx, et al. (2000) Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120 139-146.
53. NH Bell (1998) 25-Hydroxyvitamin D-1α-hydroxylases and their clinical significance. J Bone Miner Res 13 350-353.
54. MS Razzaque, D Sitara, T Taguchi, et al. (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 20 720-722.
55. HL Brenza, C Kimmel-Jehan, F Jehan, et al. (1998) Parathyroid hormone activation of the 25-hydroxylation D3–1α-hydroxylase gene promotor. Proc Natl Acad Sci U S A 95 1387-1391.
56. A Murayama, K Takeyama, S Kitanaka, et al. (1998) The promoter of the human 25-hydroxyvitamin D3 1α-hydroxylase gene confers positive and negative responsiveness to PTH, Calcitonin, and 1α,25(OH)2D3. Biochem Biophys Res Commun 249 11-16.
57. S Kato, R Fujiki, MS Kim, et al. (2007) Ligand-induced transrepressive function of VDR requires a chromatin remodeling complex, WINAC. J Steroid Biochem Mol Biol 103 372-380.
58. D Fraser, SW Kooh, HP Kind, et al. (1973) Pathogenesis of hereditary vitamin-D-dependent rickets, An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1α,25-dihydroxyvitamin D. N Engl J Med 289 817-822.
59. S Kitanaka, K Takeyama, A Murayama, et al. (1998) Inactivating mutations in the 25-hydroxyvitamin D3 1α-hydroxylase gene in patients with pseudovitamin D-deficient rickets. N Engl J Med 338 653-661.
60. Y Ohyama, M Noshiro, G Eggertsen, et al. (1993) Structural characterization of the gene encoding rat 25-hydroxyvitamin-D(3) 24-hydroxylase. Biochemistry 32 76-82.
61. D Lohnes and G Jones (1987) Side chain metabolism of vitamin D3 in osteosarcoma cell line UMR-106. J Biol Chem 262 14394-14401.
62. M Akiyoshi-Shibata, T Sakaki, Y Ohyama, et al. (1994) Further oxidation of hydroxycalcidiol by calcidiol 24-hydroxylase. A study with the mature enzyme expressed in Escherichia coli. Eur J Biochem 224 335-343.
63. R St Arnaud, A Arabian, R Travers, et al. (2000) Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 141 2658-2666.
64. MB Meyer, LA Zella, RD Nerenz, et al. (2007) Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo. J Biol Chem 282 22344-22352.
65. J Omdahl and B May (2005) The 25-hydroxyvitamin D 24-hydroxylase. D Feldman, JW Pike, FH Glorieux,(Eds) Vitamin D San Diego: Academic Press 85-104.
66. T Yoshizawa, Y Handa, Y Uematsu, et al. (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16 391-396.
67. DG Albertson, B Ylstra, R Segraves, et al. (2000) Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25 144-146.
68. GS Reddy, ML Siucaldera, I Schuster, et al. (1997) Target tissue specific metabolism of 1,25(OH)2D3 through A-ring modification. AW Norman, R Bouillon, M Thomasset,(Eds) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone Riverside, CA: University of California 139-146.
69. S Dueland, JI Pedersen, P Helgerud, et al. (1983) Absorption, distribution, and transport of vitamin-D3 and 25-hydroxyvitamin-D3 in the rat. Am J Physiol 245 E463-E467.
70. R Bouillon, H Van Baelen, W Rombauts, et al. (1976) The purification and characterisation of the human-serum binding protein for the 25-hydroxycholecalciferol (transcalciferin). Identity with group-specific component. Eur J Biochem 66 285-291.
71. J Hirschfeld (1959) Immune-electrophoretic demonstration of qualitative differences in human sera and their relation to the haptoglobins. Acta Pathol Microbiol 47 160-168.
72. WAWDJ Westwood (1986) Group-specific component: a review of the isoelectric focusing methods and auxiliary methods available for the separation of its phenotypes. Forensic Sci Int 32 135-150.
73. H Cleve and J Constants (1988) The mutants of the vitamin-D-binding protein: more than 120 variants of the GC/DBP system. Vox Sang 54 215-225.
74. NE Cooke, FF Safadi, HM Magiera, et al. (1997) Biological consequences of vitamin D binding protein deficiency in a mouse model. AW Norman, R Bouillon, M Thomasset,(Eds) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone Riverside, CA: University of California 105-111.
75. CJ Laing and NE Cooke (2005) Vitamin D binding protein. D Feldman, JW Pike, FH Glorieux,(Eds) Vitamin D San Diego: Academic Press 117-134.
76. C Verboven, A Rabijns, MM De, et al. (2002) A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol 9 131-136.
77. R Bouillon, H Van Baelen (1982) The transport of vitamin D: significance of free and total concentrations of vitamin D metabolites. AW Norman, K Schaefer, D von Herrath, et al., (Eds) Vitamin D: Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism Berlin: Walter de Gruyter 1181-1186.
78. D Vicchio, A Yergey, K Obrien, et al. (1993) Quantification and kinetics of 25-hydroxyvitamin-D3 by isotope dilution liquid chromatography/thermospray mass spectrometry. Biol Mass Spectrom 22 53-58.
79. R Kumar (1986) The metabolism and mechanism of action of 1,25-dihydroxyvitamin-D3. Kidney Intl 30 793-803.
80. R Bouillon, FA Van Assche, H Van Baelen, et al. (1981) Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. J Clin Invest 67 589-596.
81. A Nykjaer, D Dragun, D Walther, et al. (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96 507-515.
82. JF McLeod, MA Kowalski and JG Haddad (1989) Interactions among serum vitamin D binding protein, monomeric actin, profilin, and profilactin. J Biol Chem 264 1260-1267.
83. H Van Baelen, R Bouillon and P De Moor (1980) Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem 255 2270-2272.
84. PJ Goldschmidt-Clermont, H Van Baelen, R Bouillon, et al. (1988) Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit. J Clin Invest 81 1519-1527.
85. WM Lee and RM Galbraith (1992) The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326 1335-1341.
86. GK Whitfield, PW Jurutka, CA Haussler, et al. (2005) Nuclear vitamin D receptor: structure-function, molecular control of gene transcription, and novel bioactions. D Feldman, JW Pike, FH Glorieux,(Eds) Vitamin D San Diego: Academic Press 219-261.
87. K Miyamoto, RA Kesterson, H Yamamoto, et al. (1997) Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 11 1165-1179.
88. LA Crofts, MS Hancock, NA Morrison, et al. (1998) Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci USA 95 10529-10534.
89. MR Haussler, GK Whitfield, CA Haussler, et al. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13 325-349.
90. H Masuyama, Jefcoat, SC Jr and PN MacDonald (1997) The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription. Mol Endocrinol 11 218-228.
91. L Nagy, J-YCD Kao, RJ Lin, et al. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89 373-380.
92. D Chakravarti, VJ LaMorte, MC Nelson, et al. (1996) Role of CBP/P300 in nuclear receptor signalling. Nature 383 99-103.
93. Y Kamei, L Xu, T Heinzel, et al. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 403-414.
94. C Rachez and LP Freedman (2000) Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene 246 9-21.
95. TE Spencer, G Jenster, MM Burcin, et al. (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389 194-198.
96. C Rachez, M Gamble, CP Chang, et al. (2000) The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol Cell Biol 20 2718-2726.
97. H Kitagawa, R Fujiki, K Yoshimura, et al. (2003) The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113 905-917.
98. B Li, M Carey and JL Workman (2007) The role of chromatin during transcription. Cell 128 707-719.
99. A Villagra, F Cruzat, L Carvallo, et al. (2006) Chromatin remodeling and transcriptional activity of the bone-specific osteocalcin gene require CCAAT/enhancer-binding protein beta-dependent recruitment of SWI/SNF activity. J Biol Chem 281 22695-22706.
100. H Li and JD Chen (1998) The receptor-associated coactivator 3 activates transcription through CREB-binding protein recruitment and autoregulation. J Biol Chem 273 5948-5954.
101. RM Lavinsky, K Jepsen, T Heinzel, et al. (1998) Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A 95 2920-2925.
102. C Carlberg (1996) The concept of multiple vitamin D signaling pathways. J Invest Dermatol Symp Proc 1 10-14.
103. AW Norman, MT Mizwicki and DP Norman (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3 27-41.
104. A Revelli, M Massobrio and J Tesarik (1998) Nongenomic effects of 1α,25-dihydroxyvitamin D3. Trends Endocrinol Metab 9 419-422.
105. AW Norman, LP Zanello, X De Song, et al. (1997) Effectiveness of 1α,25(OH)2-vitamin D3-mediated signal transduction for genomic and rapid biological responses is dependent upon the conformation of the signaling ligand. AW Norman, R Bouillon, M Thomasset,(Eds) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone Riverside, CA: University of California 331-333.
106. AW Norman, R Bouillon, MC Farach-Carson, et al. (1993) Demonstration that 1b,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1α,25-dihydroxyvitamin D3. J Biol Chem 268 20022-20030.
107. X Song, JE Bishop, WH Okamura, et al. (1998) Stimulation of phosphorylation of mitogen-activated protein kinase by 1α,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: a structure-function study. Endocrinology 139 457-468.
108. AW Norman, WH Okamura, MC Farach-Carson, et al. (1993) Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin-D endocrine system. 1,25-Dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses. J Biol Chem 268 13811-13819.
109. TM Strom and H Juppner (2008) PHEX, FGF23, DMP1 and beyond. Curr Opin Nephrol Hypertens 17 357-362.
110. T Taketani, K-I Miyamoto, K Tanaka, et al. (1997) Gene structure and functional analysis of the human Na+/phosphate co-transporter. Biochem J 324 927-937.
111. RH Wasserman (2005) Vitamin D and the intestinal absorption of calcium: a view and overview. D Feldman, JW Pike, FH Glorieux,(Eds) Vitamin D San Diego: Academic Press 411-428.
112. SJ Van Cromphaut, M Dewerchin, JG Hoenderop, et al. (2001) Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A 98 13324-13329.
113. JJ Feher (1983) Facilitated calcium diffusion by intestinal calcium-binding protein. Cell Physiol 13 C303-C307.
114. TL Pannabecker, JS Chandler and RH Wasserman (1995) Vitamin D-dependent transcriptional regulation of the intestinal plasma membrane calcium pump. Biochem Biophys Res Commun 213 499-505.
115. YC Li, AE Pirro, M Amling, et al. (1997) Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A 94 9831-9835.
116. RG Erben, DW Soegiarto, K Weber, et al. (2002) Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 16 1524-1537.
117. O Dardenne, J Prud’homme, A Arabian, et al. (2001) Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142 3135-3141.
118. DK Panda, D Miao, ML Tremblay, et al. (2001) Targeted ablation of the 25-hydroxyvitamin-D 1-alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 98 7498-7503.
119. O Dardenne, J Prud’homme, SA Hacking, et al. (2003) Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin-D 1-alpha-hydroxylase (CYP27B1). Bone 32 332-340.
120. M Amling, M Priemel, T Holzmann, et al. (1999) Rescue of the skeletal phenotype of vitamin D receptor–ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140 4982-4987.
121. O Dardenne, J Prudhomme, SA Hacking, et al. (2003) Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res 18 637-643.
122. JG Hoenderop, O Dardenne, AM Van, et al. (2002) Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3–1α-hydroxylase knockout mice. FASEB J 16 1398-1406.
123. YC Li, M Amling, AE Pirro, et al. (1998) Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139 4391-4396.
124. MJ Rowling, C Gliniak, J Welsh, et al. (2007) High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. J Nutr 137 2608-2615.
125. Y Song, S Kato and JC Fleet (2003) Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 133 374-380.
126. S Balsan, M Garabedian, M Larchet, et al. (1986) Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 77 1661-1667.
127. Z Hochberg, D Tiosano and L Even (1992) Calcium therapy for calcitriol-resistant rickets. J Pediatr 121 803-808.
128. L Lieben, R Masuyama, K Moermans, et al. (2008) Intestinal-specific vitamin D receptor null mice maintain normal calcemia but display severe bone loss. J Bone Miner Res ASBMR Abstracts:SA238
129. BS Benn, D Ajibade, A Porta, et al. (2008) Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology 149 3196-3205.
130. H Fujita, K Sugimoto, S Inatomi, et al. (2008) Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol Biol Cell 19 1912-1921.
131. KY Renkema, T Nijenhuis, BC van der Eerden, et al. (2005) Hypervitaminosis D mediates compensatory Ca2+ hyperabsorption in TRPV5 knockout mice. J Am Soc Nephrol 16 3188-3195.
132. T Okano, N Tsugawa, S Masuda, et al. (1989) Regulatory activities of 2b-(3-hydroxypropoxy)-1α,25-dihydroxy- vitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism. Biochem Biophys Res Commun 163 1444-1449.
133. MW Tilyard, GFS Spears, J Thomson, et al. (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326 357-362.
134. EM Gardiner, NA Sims, GP Thomas, et al. (1998) Elevated osteoblastic vitamin D receptor in transgenic mice yields stronger bones. Bone 23 176.
135. MM Donohue and MB Demay (2002) Rickets in VDR null mice is secondary to decreased apoptosis of hypertrophic chondrocytes. Endocrinology 143 3691-3694.
136. Y Sabbagh, TO Carpenter and MB Demay (2005) Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci U S A 102 9637-9642.
137. R Masuyama, I Stockmans, S Torrekens, et al. (2006) Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116 3150-3159.
138. DD Bikle and S Pillai (1993) Vitamin D, calcium, and epidermal differentiation. Endocr Rev 14 3-19.
139. DD Bikle, S Chang, D Crumrine, et al. (2004) 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol 122 984-992.
140. BA Gilchrest (2008) Sun exposure and vitamin D sufficiency. Am J Clin Nutr 88 570S-577S.
141. De HP, M Garmyn, A Verstuyf, et al. (2005) 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J Photochem Photobiol B 78 141-148.
142. R Gupta, KM Dixon, SS Deo, et al. (2007) Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol 127 707-715.
143. SS Jensen, MW Madsen, J Lukas, et al. (2001) Inhibitory effects of 1-alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol 15 1370-1380.
144. K Colston, MJ Colston and D Feldman (1981) 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108 1083-1086.
145. E Abe, C Miyaura, H Sakagami, et al. (1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A 78 4990-4994.
146. L Verlinden, G Eelen, I Beullens, et al. (2005) Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3. J Biol Chem 280 37319-37330.
147. J Moreno, AV Krishnan, DM Peehl, et al. (2006) Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway. Anticancer Res 26 2525-2530.
148. O Aguilera, C Pena, JM Garcia, et al. (2007) The Wnt antagonist DICKKOPF-1 gene is induced by 1-alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28 1877-1884.
149. WM Tong, E Kallay, H Hofer, et al. (1998) Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D3 is mediated by mutual modulation of receptor expression. Eur J Cancer 34 2119-2125.
150. T Vink-van Wijngaarden, HA Pols, CJ Buurman, et al. (1996) Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089. Eur J Cancer 32A 842-848.
151. L Verlinden, A Verstuyf, R Convents, et al. (1998) Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol Cell Endocrinol 142 57-65.
152. PH Reitsma, PG Rothberg, SM Astrin, et al. (1983) Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature 306 492-494.
153. K Matsumoto, K Hashimoto, Y Nishida, et al. (1990) Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun 166 916-923.
154. T Mercier, C Chaumontet, I Gaillard-Sanchez, et al. (1996) Calcitriol and lexicalcitol (KH1060) inhibit the growth of human breast adenocarcinoma cells by enhancing transforming growth factor-beta production. Biochem Pharmacol 52 505-510.
155. Y Wu, JD Haugen, AR Zinsmeister, et al. (1997) 1 alpha,25-dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells. Biochem Biophys Res Commun 239 734-739.
156. F Rozen and M Pollak (1999) Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins. Int J Oncol 15 589-594.
157. J Welsh (2007) Targets of vitamin D receptor signaling in the mammary gland. J Bone Miner Res 22 V86-V90.
158. R Bouillon, G Eelen, L Verlinden, et al. (2006) Vitamin D and cancer. J Steroid Biochem Mol Biol 102 156-162.
159. DM Freedman, AC Looker, SC Chang, et al. (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99 1594-1602.
160. CF Garland, ED Gorham, SB Mohr, et al. (2007) Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 103 708-711.
161. E Giovannucci (2007) Strengths and limitations of current epidemiologic studies: vitamin D as a modifier of colon and prostate cancer risk. Nutr Rev 65 S77-S79.
162. R Bouillon, H Bischoff-Ferrari and W Willett (2008) Vitamin D and health: perspectives from mice and man. J Bone Miner Res 23 974-979.
163. J Wactawski-Wende, JM Kotchen, GL Anderson, et al. (2006) Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354 684-696.
164. JM Lappe, D Travers-Gustafson, KM Davies, et al. (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85 1586-1591.
165. L Overbergh, K Stoffels, M Waer, et al. (2006) Immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. J Clin Endocrinol Metab 91 3566-3574.
166. K Stoffels, L Overbergh, A Giulietti, et al. (2006) Immune regulation of 25-hydroxyvitamin-D3–1α-hydroxylase in human monocytes. J Bone Miner Res 21 37-47.
167. K Stoffels, L Overbergh, R Bouillon, et al. (2007) Immune regulation of 1α-hydroxylase in murine peritoneal macrophages: unravelling the IFNgamma pathway. J Steroid Biochem Mol Biol 103 567-571.
168. M Kankova, W Luini, M Pedrazzoni, et al. (1991) Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 73 466-471.
169. A Giulietti, C Gysemans, K Stoffels, et al. (2004) Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 47 451-462.
170. TY Chan (2000) Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int 66 476-478.
171. PDO Davies, RC Brown and JS Woodhead (1985) Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 40 187-190.
172. JM Grange, PDO Davies, RC Brown, et al. (1985) A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 66 187-191.
173. WR Waters, MV Palmer, BJ Nonnecke, et al. (2004) Mycobacterium bovis infection of vitamin D-deficient NOS2-/- mice. Microb Pathog 36 11-17.
174. RJ Wilkinson, M Llewelyn, Z Toossi, et al. (2000) Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355 618-621.
175. PT Liu, S Stenger, H Li, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 1770-1773.
176. MM Morcos, AA Gabr, S Samuel, et al. (1998) Vitamin D administration to tuberculous children and its value. Boll Chim Farm 137 157-164.
177. EW Nursyam, Z Amin and CM Rumende (2006) The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 38 3-5.
178. JB Zella and HF DeLuca (2003) Vitamin D and autoimmune diabetes. J Cell Biochem 88 216-222.
179. N Liu, L Nguyen, RF Chun, et al. (2008) Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 149 4799-4808.
180. C Mathieu, C Gysemans, A Giulietti, et al. (2005) Vitamin D and diabetes. Diabetologia 48 1247-1257.
181. SW Guo, VL Magnuson, JJ Schiller, et al. (2006) Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. Am J Epidemiol 164 711-724.
182. R Bailey, JD Cooper, L Zeitels, et al. (2007) Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56 2616-2621.
183. KL Munger, LI Levin, BW Hollis, et al. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296 2832-2838.
184. S Yu and MT Cantorna (2008) The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A 105 5207-5212.
185. YC Li, J Kong, M Wei, et al. (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110 229-238.
186. JP Forman, E Giovannucci, MD Holmes, et al. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49 1063-1069.
187. R Scragg, M Sowers and C Bell (2007) Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20 713-719.
188. K Aihara, H Azuma, M Akaike, et al. (2004) Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 279 35798-35802.
189. TJ Wang, MJ Pencina, SL Booth, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 503-511.
190. J Hsia, G Heiss, H Ren, et al. (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115 846-854.
191. M Teng, M Wolf, E Lowrie, et al. (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349 446-456.
192. SC Palmer, DO McGregor, P Macaskill, et al. (2007) Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 147 840-853.
193. I Endo, D Inoue, T Mitsui, et al. (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144 5138-5144.
194. HA Bischoff-Ferrari, B wson-Hughes, JA Baron, et al. (2007) Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 86 1780-1790.
195. HA Bischoff-Ferrari, B wson-Hughes, WC Willett, et al. (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291 1999-2006.
196. AW Norman, BJ Frankel, AM Heldt, et al. (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209 823-825.
197. BL Nyomba, R Bouillon and MP De (1984) Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology 115 191-197.
198. ES Ford, UA Ajani, LC McGuire, et al. (2005) Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28 1228-1230.
199. E Hypponen, BJ Boucher, DJ Berry, et al. (2008) 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57 298-305.
200. NG Forouhi, J Luan, A Cooper, et al. (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57 2619-2625.
201. IH de Boer, LF Tinker, S Connelly, et al. (2008) Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 31 701-707.
202. AG Pittas, SS Harris, PC Stark, et al. (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30 980-986.
203. H Dobnig, S Pilz, H Scharnagl, et al. (2008) Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168 1340-1349.
204. ML Melamed, ED Michos, W Post, et al. (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168 1629-1637.
205. M Wolf, A Shah, O Gutierrez, et al. (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72 1004-1013.
206. P Autier and S Gandini (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167 1730-1737.
207. CE Porteous, RD Coldwell, DJH Trafford, et al. (1987) Recent developments in the measurement of vitamin D and its metabolites in human body fluids. J Steroid Biochem 28 785-801.
208. R Bouillon (1983) Radiochemical assays for vitamin D metabolites: technical possibilities and clinical applications. J Steroid Biochem 19 921-927.
209. H Schmidt-Gayk, R Bouillon and HJ Roth (1997) Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance. Scand J Clin Lab Invest 57 35-45.
210. N Binkley, D Krueger, D Gemar, et al. (2008) Correlation among 25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 93 1804-1808.
211. P Lips, MC Chapuy, B Dawson-Hughes, et al. (1999) An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 9 394-397.
212. Z Maunsell, DJ Wright and SJ Rainbow (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51 1683-1690.
213. MR Clements, L Johnson and DR Fraser (1987) A new mechanism for induced vitamin-D deficiency in calcium deprivation. Nature 325 62-65.
214. R Bouillon and H Van Baelen (1981) Transport of vitamin D: significance of free and total concentrations of the vitamin D metabolites. Calcif Tissue Int 33 451-453.
215. DD Bikle and E Gee (1989) Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 124 649-654.
216. G Vanham, H Van Baelen, BK Tan, et al. (1988) The effect of vitamin D analogs and of vitamin D-binding protein on lymphocyte proliferation. J Steroid Biochem 29 381-386.
217. R Bouillon, H Van Baelen (1979) The transport of vitamin D. AW Norman, K Schaefer, D von Herrath, et al., (Eds) Vitamin D: Basic Research and Its Clinical Application Berlin: Walter de Gruyter 137-143.
218. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Food and Nutrition Board Washington: National Academy Press 1-30.
219. Lerch C, Meissner T: Interventions for the prevention of nutritional rickets in term born children, Cochrane Database Syst Rev CD00:61–64, 2007.
220. E Beser and T Cakmakci (1994) Factors affecting the morbidity of vitamin D deficiency rickets and primary protection. East Afr Med J 71 358-362.
221. CL Wagner and F Greer (2008) R, the section on breastfeeding and committee on nutrition: Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 122 1142-1152.
222. GI Baroncelli, A Bereket, KM El, et al. (2008) Rickets in the Middle East: role of environment and genetic predisposition. J Clin Endocrinol Metab 93 1743-1750.
223. I van der Meer, NS Karamali, AJ Boeke, et al. (2006) High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am J Clin Nutr 84 350-353.
224. JM Pettifor (2005) Rickets and vitamin D deficiency in children and adolescents. Endocrinol Metab Clin North Am 34 537-553. vii
225. MK Javaid, SR Crozier, NC Harvey, et al. (2006) Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 367 36-43.
226. RA Bouillon, JH Auwerx, WD Lissens, et al. (1987) Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr 45 755-763.
227. A Malabanan, IE Veronikis and MF Holick (1998) Redefining vitamin D insufficiency. Lancet 351 805-806.
228. RP Heaney, MS Dowell, CA Hale, et al. (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22 142-146.
229. RP Heaney (2007) The case for improving vitamin D status. J Steroid Biochem Mol Biol 103 635-641.
230. AG Need, PD O’Loughlin, HA Morris, et al. (2008) Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 23 1859-1863.
231. SA Abrams, IJ Griffin, KM Hawthorne, et al. (2005) Relationships among vitamin D levels, parathyroid hormone, and calcium absorption in young adolescents. J Clin Endocrinol Metab 90 5576-5581.
232. K Zhu, D Bruce, N Austin, et al. (2008) Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency. J Bone Miner Res 23 1343-1348.
233. KE Hansen, AN Jones, MJ Lindstrom, et al. (2008) Vitamin D insufficiency: disease or no disease? J Bone Miner Res 23 1052-1060.
234. ME Ooms, P Lips, JC Roos, et al. (1995) Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10 1177-1184.
235. JA Cauley, AZ LaCroix, L Wu, et al. (2008) Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 149 242-250.
236. S Boonen, P Lips, R Bouillon, et al. (2007) Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92 1415-1423.
237. IR Reid, MJ Bolland and A Grey (2008) Effect of calcium supplementation on hip fractures. Osteoporos Int 19 1119-1123.
238. HA Bischoff-Ferrari, JR Rees, MV Grau, et al. (2008) Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial. Am J Clin Nutr 87 1945-1951.
239. RP Heaney, LA Armas, JR Shary, et al. (2008) 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 87 1738-1742.
240. C Roux, HA Bischoff-Ferrari, SE Papapoulos, et al. (2008) New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion. Curr Med Res Opin 24 1363-1370.
241. V Chel, HA Wijnhoven, JH Smit, et al. (2008) Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 19 663-671.
242. R Vieth (2007) Vitamin D toxicity, policy, and science. J Bone Miner Res 22(Suppl 2)), V64-V68.
243. T Hagenau, R Vest, TN Gissel, et al. (2008) Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int 20 133-140.
244. MC Chapuy, P Preziosi, M Maamer, et al. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7 439-443.
245. RP van der Wielen, MR Lowik, BH van den, et al. (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346 207-210.
246. SA Rahman, WS Chee, Z Yassin, et al. (2004) Vitamin D status among postmenopausal Malaysian women. Asia Pac J Clin Nutr 13 255-260.
247. DR Fraser (2004) Vitamin D-deficiency in Asia. J Steroid Biochem Mol Biol 89–90 491-495.
248. I van der Mei, AL Ponsonby, O Engelsen, et al. (2007) The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect 115 1132-1139.
249. R Bouillon, AW Norman and P Lips (2007) Vitamin D deficiency. N Engl J Med 357 1980-1981.
250. R Bouillon, M Garmyn, A Verstuyf, et al. (1995) Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. Eur J Endocrinol 133 7-16.
251. R Bouillon, WH Okamura and AW Norman (1995) Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16 200-257.
252. G Eelen, C Gysemans, L Verlinden, et al. (2007) Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr Med Chem 14 1893-1910.
253. A Verstuyf, L Verlinden, H Van Baelen, et al. (1998) The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings. J Bone Miner Res 13 549-558.
254. G Eelen, N Valle, Y Sato, et al. (2008) Superagonistic fluorinated vitamin D(3) analogs stabilize helix 12 of the vitamin D receptor. Chem Biol 15 1029-1034.
255. S Peleg, C Nguyen, BT Woodard, et al. (1998) Differential use of transcription activation function 2 domain of the vitamin D receptor by 1,25-dihydroxyvitamin D3 and its A ring-modified analogs. Mol Endocrinol 12 525-535.
256. Y-Y Liu, ED Collins, AW Norman, et al. (1997) Differential interaction of 1α,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor. J Biol Chem 272 3336-3345.
257. GJCM van den Bemd, HAP Pols, JC Birkenhager, et al. (1996) Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060. Proc Natl Acad Sci U S A 93 10685-10690.
258. N Rochel, JM Wurtz, A Mitschler, et al. (2000) The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 5 173-179.
259. R Bouillon, K Allewaert, DZ Xiang, et al. (1991) Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity. J Bone Miner Res 6 1051-1057.
260. AS Dusso, L Negrea, S Gunawardhana, et al. (1991) On the mechanisms for the selective action of vitamin D analogs. Endocrinology 128 1687-1692.
261. T Matsumoto, T Miki, H Hagino, et al. (2005) A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 90 5031-5036.
262. HZ Ke, H Qi, DT Crawford, et al. (2005) A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia. J Bone Miner Res 20 1742-1755.
263. TM Beer, KM Eilers, M Garzotto, et al. (2003) Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J Clin Oncol 21 123-128.
264. K Fogh and K Kragballe (1997) Vitamin D3 analogues. Clin Dermatol 15 705-713.
265. PCM Van de Kerkhof (1996) Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs. J Invest Dermatol Symp Proc 1 78-81.
266. I Lu, P Gilleaudeau, JA McLane, et al. (1996) Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infiltration in psoriatic plaques by topical calcitriol. J Cutan Pathol 23 419-430.
267. K Casteels, R Bouillon, M Waer, et al. (1995) Immunomodulatory effects of 1,25-dihydroxyvitamin D3. Curr Opin Nephrol Hypertens 4 313-318.
268. F Baeke, E Van Etten, L Overbergh, et al. (2007) Vitamin D3 and the immune system: maintaining the balance in health and disease. Nutr Res Rev 20 106-118.
269. E Van Etten and C Mathieu (2005) Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97 93-101.
270. C Mathieu and L Adorini (2002) The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8 174-179.
271. L Adorini, G Penna, S Amuchastegui, et al. (2007) Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol). J Steroid Biochem Mol Biol 103 689-693.
272. B Dawson-Hughes, RP Heaney, MF Holick, et al. (2005) Estimates of optimal vitamin D status. Osteoporos Int 16 713-716.